BPG is committed to discovery and dissemination of knowledge
Expert Consensus
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Table 3 India-specific risk stratification[4]

Strong
Moderate
Mild
No effect
Donor-related factorsDonor-recipient age matchingOlder donor age-Deceased donor; ECD/cause of death/non-heart beating1; diabetes/hypertension, polycystic kidney disease; HCV status
Recipient-related factorsDonor-recipient age matching; HLA mismatch; presence of anti-HLA antibodies; presence of pre-transplant DSA and DSA titerPRARe-transplantation-
Transplant-related factorsDelayed graft function-Cold ischemia timeCMV/HIV/HCV infection1; gender; high BMI

  • Citation: Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367
  • URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114367

Write to the Help Desk